Regulatory T-Cell Generation and Kidney Allograft Tolerance Induced by Mesenchymal Stem Cells Associated With Indoleamine 2,3-Dioxygenase Expression

被引:285
作者
Ge, Wei
Jiang, Jifu
Arp, Jacqueline
Liu, Weihua [2 ]
Garcia, Bertha [2 ]
Wang, Hao [1 ,2 ,3 ]
机构
[1] Univ Western Ontario, Univ Hosp, London Hlth Sci Ctr, Multiorgan Transplant Program,Dept Surg, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada
[3] London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON, Canada
基金
加拿大创新基金会;
关键词
Tolerance; Regulatory T cells; Mesenchymal stem cells; Kidney transplantation; Indoleamine 2,3-dioxygenase; MARROW STROMAL CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROLIFERATION IN-VITRO; VERSUS-HOST-DISEASE; BONE-MARROW; DENDRITIC CELLS; TRANSPLANT RECIPIENTS; GRAFT-SURVIVAL; INHIBIT; IMMUNOSUPPRESSION;
D O I
10.1097/TP.0b013e3181fed001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The immunoregulatory properties of mesenchymal stem cells (MSCs) have been observed in vitro and in vivo. However, the underlying mechanisms of this immunomodulation remain undefined. Recent research demonstrated that MSCs express the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), known to suppress T-cell responses. This study was designed to address whether MSCs induce kidney allograft tolerance and whether IDO contributes to the immunoregulatory functions of MSCs in vivo. Methods. MSCs (1 x 10(6), intravenously) from wild-type (WT-MSCs) or IDO knockout (IDO-/--MSCs) C57BL/6 mice were injected into BALB/c recipients 24 hr after receiving a life-supporting orthotopic C57BL/6 renal graft. Results. WT-MSC-treated recipients achieved allograft tolerance with normal histology and undetectable antidonor antibody levels. Tolerant recipients demonstrated increased circulating kynurenine levels and significantly high frequencies of tolerogenic dendritic cells. They also exhibited significantly impaired CD4(+) T-cell responses consisting of decreased donor-specific proliferative ability and a Th2-dominant cytokine shift. In addition, high frequencies of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) were found in recipient spleens and donor grafts, with antibody-induced CD25(+) cell depletion confirming the critical role of Tregs in the MSC-induced tolerance. Interestingly, renal allograft recipients treated with WT MSCs concomitant with the IDO inhibitor 1-methyl-tryptophan, or those treated with IDO-/--MSCs alone, were unable to achieve allograft tolerance-revealing that functional IDO was necessary for the immunosuppression observed with WT-MSC treatment. Conclusions. IDO secreted by MSCs was responsible, at least in part, for induction of kidney allograft tolerance through generation of Tregs. This study supports the clinical application of MSCs in transplantation.
引用
收藏
页码:1312 / 1320
页数:9
相关论文
共 57 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth:: role of stromal cells in follicular lymphoma pathogenesis [J].
Ame-Thomas, Patricia ;
Maby-El Hajjami, Helene ;
Monvoisin, Celine ;
Jean, Rachel ;
Monnier, Delphine ;
Caulet-Maugendre, Sylvie ;
Guillaudeux, Thierry ;
Lamy, Thierry ;
Fest, Thierry ;
Tarte, Karin .
BLOOD, 2007, 109 (02) :693-702
[3]  
[Anonymous], CANC J
[4]   Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo [J].
Aslam, R ;
Speck, ER ;
Kim, M ;
Crow, AR ;
Bang, KWA ;
Nestel, FP ;
Ni, HY ;
Lazarus, AH ;
Freedman, J ;
Semple, JW .
BLOOD, 2006, 107 (02) :637-641
[5]   Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells [J].
Aslam, Rukhsana ;
Speck, Edwin R. ;
Kim, Michael ;
Freedman, John ;
Semple, John W. .
TRANSFUSION, 2008, 48 (09) :1778-1786
[6]   Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation [J].
Ball, Lynne M. ;
Bernardo, Maria Ester ;
Roelofs, Helene ;
Lankester, Arjan ;
Cometa, Angela ;
Egeler, R. Maarten ;
Locatelli, Franco ;
Fibbe, Willem E. .
BLOOD, 2007, 110 (07) :2764-2767
[7]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[8]   Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves [J].
Batten, Puspa ;
Sarathchandra, Padmini ;
Antoniw, Joseph W. ;
Tay, Szun Szun ;
Lowdell, Mark W. ;
Taylor, Patricia M. ;
Yacoub, Magdi H. .
TISSUE ENGINEERING, 2006, 12 (08) :2263-2273
[9]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[10]   Basic mechanisms of humoral rejection [J].
Cascalho, M ;
Platt, JL .
PEDIATRIC TRANSPLANTATION, 2005, 9 (01) :9-16